Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 250,000 | reported | 02 Jan 2026 | tx 2+650,000 |
| FATE THERAPEUTICS INC | 186,000 | reported | 16 Jan 2018 | tx 5+582,683 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Design Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |
| 16 Jan 2018 | GRANT_AWARD | FATE THERAPEUTICS INC | 186,000 | — | deriv |
| 04 Jan 2017 | GRANT_AWARD | FATE THERAPEUTICS INC | 150,000 | — | deriv |
| 23 Nov 2016 | PURCHASE | FATE THERAPEUTICS INC | 37,593 | 2.66 USD | |
| 16 May 2016 | GRANT_AWARD | FATE THERAPEUTICS INC | 9,090 | 0.00 USD | |
| 16 May 2016 | GRANT_AWARD | FATE THERAPEUTICS INC | 200,000 | — | deriv |